Securities code: 300970 securities abbreviation: Jiangsu Chinagreen Biological Technology Co.Ltd(300970) Announcement No.: 2022-003 Jiangsu Chinagreen Biological Technology Co.Ltd(300970)
Announcement on the resolution of the 11th meeting of the 4th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
The 11th meeting of the 4th board of directors of Jiangsu Chinagreen Biological Technology Co.Ltd(300970) (hereinafter referred to as “the company”) was held on February 9, 2022 in the conference room on the second floor of the company by means of on-site and communication, and the meeting notice was sent to all directors by means of communication on February 4, 2022. The meeting was convened and presided over by Mr. Yu Yangchao, chairman of the board of directors. There were 9 directors who should attend the meeting, and 9 directors actually attended the meeting, including Mr. Yu Yangchao, Mr. Fan Liping, Mr. Feng Zhan, Ms. Yu Liqin, Ms. Xie Nan, Mr. Li Zhengming and Mr. Wu Xiaoping. Supervisors and senior managers of the company attended the meeting as nonvoting delegates. The convening, convening and voting of the meeting shall comply with the company law, the articles of association and other relevant provisions.
2、 Deliberations of the board meeting
The directors attending the meeting carefully considered the following proposals, and considered and adopted the following proposals by means of on-site voting and communication voting:
(I) the proposal on signing an investment agreement and establishing a holding subsidiary in Jiangzhou District, Chongzuo city was deliberated and adopted
For details, please refer to the company’s website on the same day (www.cn. Info. Com. CN.) Announcement on signing the investment agreement and planning to establish a holding subsidiary in Jiangzhou District, Chongzuo City (Announcement No.: 2022-002).
Voting results: 9 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(II) the proposal on requesting the general meeting of shareholders to authorize the board of directors or persons authorized by the board of directors to handle relevant industrial and commercial change and establishment registration was deliberated and adopted
The company intends to request the general meeting of shareholders to authorize the board of directors or the person authorized by the board of directors to handle relevant matters such as industrial and commercial change and establishment registration. The validity period of the authorization is from the date of deliberation and approval by the general meeting of shareholders to the date of completion of the relevant industrial and commercial change registration and filing. The specific content of this change is finally subject to the industrial and commercial registration. Voting results: 9 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(III) the proposal on convening the first extraordinary general meeting of shareholders in 2022 was reviewed and approved. The company plans to hold the first extraordinary general meeting of shareholders in 2022 on February 25, 2022. The shareholders’ meeting was held by combining on-site voting and online voting.
For details, please refer to the company’s website on the same day (www.cn. Info. Com. CN.) Announcement on the notice of convening the first extraordinary general meeting of shareholders in 2022 (Announcement No.: 2022-004).
Voting results: 9 in favor, 0 against and 0 abstention.
3、 Documents for future reference
1. Resolution of the 11th meeting of the 4th board of directors of the company.
It is hereby announced.
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) board of directors February 9, 2022
